Journal News

Study uncovers aspect of how muscular dystrophies progress

Olga Kuchment
By Olga Kuchment
April 1, 2023

A research study has shed new light on how congenital muscular dystrophies such as Walker–Warburg syndrome progress, bringing hope for better understanding, early diagnosis and treatments of these fatal disorders.

Published in March in the Journal of Biological Chemistry, the research was led by scientists in the lab of Vlad Panin, professor in the Department of Biochemistry and Biophysics in the Texas A&M College of Agriculture and Life Sciences. The study is titled “Protein tyrosine phosphatase 69D is a substrate of protein O-mannosyltransferases 1-2 that is required for the wiring of sensory axons in Drosophila.” The primary author is Pedro Monagas–Valentin, one of Panin’s doctoral students.

The study uncovers new ways of how genetic mutations seen in patients with muscular dystrophies may lead to disease and create neurological problems. Namely, the mutations disrupt a newly discovered gene function and prevent neurons from forming connections properly. The research used fruit flies as a model system and has implications for humans.

This fruit fly brain shows the mutation the new study links to muscular dystrophies. The fly has wiring defects in sensory axons, pictured in fluorescent green. (Image courtesy of Pedro Monagas-Valentin)
Courtesy of Pedro Monagas–Valentin
This fruit fly brain shows the mutation the new study links to muscular dystrophies. The fly has wiring defects in sensory axons, pictured in fluorescent green.

Funders of the research included the National Institutes of Health and the Texas A&M AgriLife Institute for Advancing Health Through Agriculture.

Walker–Warburg syndrome and other muscular dystrophies

Walker–Warburg and muscle-eye-brain syndromes are rare, severe muscular dystrophies. Typically diagnosed in very young children, these conditions progress rapidly. They affect skeletal, heart and lung muscles as well as the brain, eyes and other organs. No cure exists for these diseases, and patients usually do not survive into adulthood.

“Certain genes affected in these disorders are known,” Panin said. “But much remains unknown about how these genetic defects affect molecular and cellular processes to cause neurological and other problems.”

This gap in understanding of pathological mechanisms impedes the development of treatments and efficient diagnostics, he said.

A problem tied to sugar biology

Many of the genetic mutations that occur with muscular dystrophies affect something difficult to study, Panin said, and that is the way our bodies build and use complex sugars.

The sugars, called glycans, are made by all living things. In addition to energy storage and regulation, glycans have countless functions that regulate other molecules in animal cells.

“There are four ‘languages’ of life, if you think about it in general,” Panin said. “Two are proteins and nucleic acids like DNA and RNA. And there are two more languages: lipids and glycans. The fourth one is arguably the most complex ‘language,’ and this is what we study as glycobiologists.”

Glycans can be complex and branching. Unlike DNA or proteins, they are not created from a genetic template. The mutations in muscular dystrophy patients disturb a complex chain of events needed to build and attach glycans to the right molecules inside our bodies. To understand that chain of events, scientists must study the structures and locations of glycans, and the technology to do that is still being developed.

What the team did

To track the role of several genetic mutations in muscular dystrophies, the team genetically modified fruit flies, then studied how the mutations affected the flies’ nervous system structure and glycobiology.

“My work involved a lot of crossing different lines of fruit flies to either raise or lower the activity of genes we wanted to learn more about,” Monagas–Valentin said. “Then I did a lot of fly brain dissections under the microscope, of multiple genetic combinations, with a lot of practice and a lot of messing up.”

Monagas–Valentin used fluorescence microscopy and other methods to compare how different mutations in flies affected fly bodies and brains. He also sent samples for analysis using methods specifically designed for glycobiology. For that analysis, Monagas–Valentin and Panin collaborated with researchers at the Complex Carbohydrate Research Center at the University of Georgia in Athens.

“Our collaborators have expertise in glycan sample preparation, data analysis, protocol development — every step is important,” Panin said.

Putting all the data together, the team found that a protein called PTP69D enables the proper wiring of sensory axons in flies. The researchers also revealed that the genes mutated in muscular dystrophy patients are important for PTP69D to function properly. What’s more, PTP69D belongs to a large family of proteins that have very similar structure and function in flies and humans.

“This story opens up new directions to understand neurological problems,” Panin said.

What’s next

Although PTP69D and its protein family members are similar in flies and in humans, there are limitations to what the present study says about human biology, Panin said.

“The fly nervous system is much simpler, and in humans there may be additional protein and glycan interactions in play,” Panin said. “We can see the basic mechanisms, but nuances and additional layers cannot be studied in flies.”

He said much is still unknown about the proteins and glycans involved in neuron development. The team will now study these molecules and interactions more deeply to see how mutations in muscular dystrophy genes affect individual neurons.

This article first appeared in AgriLife Today, the news hub for Texas A&M AgriLife, which brings together a college and four state agencies focused on agriculture and life sciences within The Texas A&M University System. Read the original.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Olga Kuchment
Olga Kuchment

Olga Kuchment is a communication specialist for Texas A&M AgriLife Communications in College Station. She is responsible for writing news releases and feature articles from science-based information generated or provided by AgriLife faculty throughout the state.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Scientists track 'doubling' in origin of cancer cells
News

Scientists track 'doubling' in origin of cancer cells

June 15, 2024

Researchers at Johns Hopkins say they have charted a molecular pathway that can lure cells down a hazardous path of duplicating their genome too many times.

From the journals: JBC
Journal News

From the journals: JBC

June 14, 2024

Ribosomal RNA, R-loops and the RNA exosome. Using an old drug to treat a new skin disease, Sugar-binding immune receptors. Read about recent papers on these topics.

New gene new strides in gangliosidosis
Journal News

New gene new strides in gangliosidosis

June 11, 2024

A gene that decreases disease progression in mice provides a new direction for human therapy.

Brushing with bacteria: The debate over a GMO tooth microbe
News

Brushing with bacteria: The debate over a GMO tooth microbe

June 9, 2024

One startup has said a genetically modified microbe could prevent cavities. Experts, though, have safety concerns.

Newly discovered genetic variant clarifies why Parkinson’s develops
News

Newly discovered genetic variant clarifies why Parkinson’s develops

June 8, 2024

Researchers at the University of Florida have found that the mutation called RAB32 Ser71Arg both causes the condition and could show how to halt it.

From the journals: JLR
Journal News

From the journals: JLR

June 7, 2024

Switching cancer cells from pro- to antitumor. Species-specific skeletal muscle metabolism. Protein deletion improves metabolic disorders Read about recent papers on these topics.